Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2012 by Pharmos.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Pharmos
ClinicalTrials.gov Identifier:
NCT01519687
First received: January 24, 2012
Last updated: January 26, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2012
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)